点评:继续寻找2型糖尿病的基因是否有价值?

2015-02-03 《国际糖尿病》编辑部 《国际糖尿病》

2型糖尿病是一种高度异质性的疾病,在复杂的基因背景下,营养物质过多摄入导致体内糖脂代谢异常,引起疾病发生。因此,遗传和环境是2型糖尿病发生的两大重要方面。正方Mark McCarthy和反方Mike Lean正是从这两个方面来看待目前关于2型糖尿病的研究。在遗传学方面,正如Mark McCarthy所说,通过GWAS研究和一些表观遗传学的研究从基础研究的角度在一定程度上揭示了基因在2型糖尿病发生中

2型糖尿病是一种高度异质性的疾病,在复杂的基因背景下,营养物质过多摄入导致体内糖脂代谢异常,引起疾病发生。因此,遗传和环境是2型糖尿病发生的两大重要方面。正方Mark McCarthy和反方Mike Lean正是从这两个方面来看待目前关于2型糖尿病的研究。在遗传学方面,正如Mark McCarthy所说,通过GWAS研究和一些表观遗传学的研究从基础研究的角度在一定程度上揭示了基因在2型糖尿病发生中的作用机制,但如何将其研究结果应用到临床治疗仍然需要很多工作。


Mike Lean则更看重现有研究对于2型糖尿病的临床治疗的意义,他认为减少糖尿病风险从根本上要做到保持正常体重,研究基金也应多关注生活方式调整。正反双方所关注的两大方面都是目前2型糖尿病研究的重要内容,遗传学研究从机制上对2型糖尿病的发生做出合理的解释,可为以后新药的研发和新治疗方法的出现提供理论基础,而反方提出的“应加强对生活方式调整的关注”呼吁也值得引起未来基金支持方向的调整。

正方和反方的观点都为今后糖尿病的研究提供了很好的研究方向,同时再次印证了糖尿病研究领域未知方面远多于已知,糖尿病的预防和治疗仍是我们关注的焦点。

正方:Mark McCarthy 英国牛津大学


Mark McCarthy 英国牛津大学糖尿病中心糖尿病研究团队负责人。主要研究领域是2型糖尿病及其相关表型易感基因鉴定、将基因鉴定成果向生物学和临床转化、基因组流行病学、统计遗传学和生物信息学等。

全球糖尿病患者现已超过5亿,治疗糖尿病耗费大量社会与经济资源。目前,糖尿病治疗的有效性尚存在很大不足之处,人类遗传学研究使得人们能够更加深入了解糖尿病。在未来,人类遗传学将在这一领域继续做出贡献。

单基因糖尿病是遗传学在糖尿病治疗方面贡献的有力例证。KCNJ11被证实是新生儿糖尿病发病的原因之一,这使得绝大多数新生儿糖尿病患儿能够脱离胰岛素,使用口服药物治疗。
遗传外显率和等位基因频率负相关。对2型糖尿病7年的全基因组关联(GWAS)研究发现了70个基因位点,等位基因对疾病的影响呈轻、中度,可解释5%~10%的疾病变异。如果使用全GWAS即则可达30%~50%。研究在不同种族之间具有高度一致性。基因主要为调节性,与单基因信号部分重叠。然而,2型糖尿病是一种复杂的多系统疾病,环境和表观遗传学因素也对其产生影响。

GWAS的效应值通常较小,但这并不影响其研究疾病的效果或治疗方面的潜在获益。基于人类遗传学,我们了解到许多知识,例如通过与出生体重相关的基因位点确认了宫内生长与成年体重及代谢的关系、MTNR1B基因解释了甘油三酯代谢与糖尿病之间的关系,以及HNF1A变异对C反应蛋白(CRP)水平的影响。

在未来,人类遗传学将通过探索更多的遗传位点、变异和不同基因之间的相互作用,以期在糖尿病治疗方面发挥更大作用。

反方:Mike Lean 苏格兰格拉斯哥大学



Mike Lean 苏格兰格拉斯哥大学人类营养学科室主任,格拉斯哥皇家医院顾问医生。主要研究领域是糖尿病、肥胖和人类营养学等。

2型糖尿病与营养贮藏相关,即脂肪大于身体承受能力。血糖的决定因素包括年龄、缺少运动、应激/炎症、身体脂肪含量及腹部脂肪蓄积,其中只有后两个因素和基因相关。除年龄之外,其他四个因素都能通过减重、运动等方式改善。

2型糖尿病风险随体重指数(BMI)和腰围增加而大幅度升高。DPP、DPS、XENDOS等研究显示,体重减轻4~8 kg可预防58%的新发2型糖尿病。DIRECT研究显示,使用减重手术减轻>15 kg体重可在12~24月内逆转大多数2型糖尿病。遗传学分析的确能够预测肝脏和胰腺的脂肪沉积、体重变化对异位脂肪的影响及对糖尿病的逆转,但其在个体化治疗方面的意义有限。

糖尿病治疗最重要的是少吃,多运动。研究基金也应当更多用于生活方式调整。但目前研究集中于胰岛素释放动力学、受体后胰岛素介导通路、基因相关性、表观遗传学、代谢组学及药物开发等。

2型糖尿病的确有重要的家族/遗传病因学因素,但和多基因及表观遗传学有关,因此寻找单基因和简单的药物治疗方案是徒劳的。无论基因如何,保持正常体重都能减少糖尿病发生风险。遗传/表观遗传因素只在糖尿病发病中起一部分作用,且仅在人们身体脂肪增加后才起作用。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=20393, encodeId=71cd2039327, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16704, encodeId=f6d716e04a3, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:22:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16267, encodeId=bc221626e2d, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:07:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15271, encodeId=a2e8152e18e, content=好!谢谢!不错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:27:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15003, encodeId=72d615003a5, content=几乎没有价值。一个人若无限活下去,都是糖尿病患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Feb 03 17:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14999, encodeId=de40149992e, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15000, encodeId=eb2d150002c, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-04-11 x35042875

    AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=20393, encodeId=71cd2039327, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16704, encodeId=f6d716e04a3, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:22:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16267, encodeId=bc221626e2d, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:07:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15271, encodeId=a2e8152e18e, content=好!谢谢!不错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:27:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15003, encodeId=72d615003a5, content=几乎没有价值。一个人若无限活下去,都是糖尿病患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Feb 03 17:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14999, encodeId=de40149992e, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15000, encodeId=eb2d150002c, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-02-22 orthoW

    不错的文章,学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=20393, encodeId=71cd2039327, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16704, encodeId=f6d716e04a3, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:22:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16267, encodeId=bc221626e2d, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:07:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15271, encodeId=a2e8152e18e, content=好!谢谢!不错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:27:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15003, encodeId=72d615003a5, content=几乎没有价值。一个人若无限活下去,都是糖尿病患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Feb 03 17:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14999, encodeId=de40149992e, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15000, encodeId=eb2d150002c, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-02-17 chinayinhan

    已阅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=20393, encodeId=71cd2039327, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16704, encodeId=f6d716e04a3, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:22:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16267, encodeId=bc221626e2d, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:07:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15271, encodeId=a2e8152e18e, content=好!谢谢!不错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:27:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15003, encodeId=72d615003a5, content=几乎没有价值。一个人若无限活下去,都是糖尿病患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Feb 03 17:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14999, encodeId=de40149992e, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15000, encodeId=eb2d150002c, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-02-08 xjtumed10

    好!谢谢!不错!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=20393, encodeId=71cd2039327, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16704, encodeId=f6d716e04a3, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:22:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16267, encodeId=bc221626e2d, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:07:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15271, encodeId=a2e8152e18e, content=好!谢谢!不错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:27:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15003, encodeId=72d615003a5, content=几乎没有价值。一个人若无限活下去,都是糖尿病患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Feb 03 17:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14999, encodeId=de40149992e, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15000, encodeId=eb2d150002c, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-02-03 223.104.5.**

    几乎没有价值。一个人若无限活下去,都是糖尿病患者

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=20393, encodeId=71cd2039327, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16704, encodeId=f6d716e04a3, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:22:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16267, encodeId=bc221626e2d, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:07:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15271, encodeId=a2e8152e18e, content=好!谢谢!不错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:27:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15003, encodeId=72d615003a5, content=几乎没有价值。一个人若无限活下去,都是糖尿病患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Feb 03 17:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14999, encodeId=de40149992e, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15000, encodeId=eb2d150002c, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-02-03 黄庆

    有!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=20393, encodeId=71cd2039327, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16704, encodeId=f6d716e04a3, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:22:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16267, encodeId=bc221626e2d, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:07:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15271, encodeId=a2e8152e18e, content=好!谢谢!不错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:27:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15003, encodeId=72d615003a5, content=几乎没有价值。一个人若无限活下去,都是糖尿病患者, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=223.104.5.**, createdTime=Tue Feb 03 17:19:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14999, encodeId=de40149992e, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160804/IMG57A2EF131ACE72300.jpg, createdBy=a2811610046, createdName=黄庆, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15000, encodeId=eb2d150002c, content=有!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Feb 03 11:40:00 CST 2015, time=2015-02-03, status=1, ipAttribution=)]
    2015-02-03 MedSci客户端网友

    有!

    0

相关资讯

MCP:中科院科学家揭示蛋白质丙二酰化修饰与2型糖尿病的相关性

随着人们生活水平的提高,糖尿病已经成为所有人不得不正视的问题。然而,经过这么多年的研究,科学家尚未能彻底了解清楚糖尿病的完整机理。 2015年1月1日,中科院杨福愉、杨福全等人发布在Molecular & Cellular Proteomics发表了题为“Lysine malonylation is elevated in type 2 diabetic mouse models and

JAMA:二甲双胍在2型糖尿病和肾脏疾病中的应用

普遍认为,二甲双胍是首选的治疗2型糖尿病的口服降糖药物。但是,由于其有导致乳酸酸中毒的风险,一直禁用于合并严重肾脏疾病的糖尿病患者。最近发表在JAMA上一篇文章,系统的评价合并严重肾脏疾病的糖尿病患者使用二甲双胍,出现乳酸酸中毒的风险。文章搜索了MEDLINE和 Cochrane两个数据库中,从1950年到2014年6月,所有关于二甲双胍,肾脏疾病,乳酸酸中毒的英文文献。排除了综述、快报、评论、案

NEJM:2型糖尿病 外科治疗PK内科治疗

1980 年,Pories 等行胃旁路手术治疗肥胖症时发现,合并T2DM 的病人术后血糖迅速恢复正常,甚至部分病人可不再服用降糖药物。2004 年,Ferchak 等通过前瞻性对照研究发现,合并T2DM 的肥胖病人在接受胃旁路手术后,不需要药物降糖并能长期保持血糖正常的病例数明显高于非手术组,且糖尿病相关并发症的发生率和病死率明显降低。Arterburn 等还发现病人术后出现了收缩压降低、血脂异常

Diabetes Care:吸烟与2型糖尿病长期风险研究(欧洲人群EPIC-InterAct研究)

研究者对吸烟和2型糖尿病发生之间的关系进行了研究,对于大量的潜在混合因素进行分析,并探讨了潜在的效应修饰和中介因素。研究表明,与不吸烟的男性和女性相比,曾经吸烟和目前吸烟是2型糖尿病的发生相关的高风险因素,其独立于教育水平、体力活动、饮酒、饮食。因此,吸烟可作为2型糖尿病的一个危险因素,应鼓励戒烟预防糖尿病。本研究结果发表于最新一期《糖尿病治疗》上(Diabetes Care December 2

Lancet Diab & Endo:2型糖尿病患者应注意心血管疾病风险!

流行病学研究表明,肥胖、高热量饮食、体力活动不足及增龄是2型糖尿病最主要的环境因素,高血压、血脂异常等因素也会增加患病风险。但是目前,2型糖尿病与大多数心血管疾病的发病之间的关系尚未得到明确的报道。因此,来自英国伦敦大学的Shah教授带领了研究组进行了一项包含了一百九十万人群的队列研究,试图寻找2型糖尿病与12种心血管疾病的初始表现间的关联。该研究结果发表于The Lancet Diabete

Circ Heart Fail:HbA1c水平可以预测T2DM心衰事件发生率

2型糖尿病目前公认的独立于冠状动脉粥样硬化性疾病和高血压病的发生心衰的独立风险因素, 且血糖控制水平会影响心衰发生率。高血糖会加重心肌损伤,同时上调肾素-血管紧张素-醛固酮系统,增加氧化应激。高血糖症也与心肌细胞脂毒性、线粒体功能障碍、钙处理受损等有关,流行病学证据,证明HbA1c与心衰发生风险相关。但是尚无具体的研究来评估T2DM心衰发生率和血糖控制水平之间的关系。最近,来自英国的Helen M